Regulation of neurotransmitter interactions in the ventral striatum

Annals of the New York Academy of Sciences

Volumn 877, Issue , 1999, Pages 129-139

  McGinty, Jacqueline F ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; AMPHETAMINE; CALCIUM; COCAINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIZOCILPINE; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ENDORPHIN; ETICLOPRIDE; EXCITATORY AMINO ACID RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROPEPTIDE; NEUROTRANSMITTER; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; PSYCHOSTIMULANT AGENT; RETINOIC ACID RECEPTOR; SCOPOLAMINE; TRANSCRIPTION FACTOR; UNINDEXED DRUG;

CONFERENCE PAPER; CORPUS STRIATUM; FOREBRAIN; GENE EXPRESSION; HORMONE RECEPTOR INTERACTION; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROCHEMISTRY; NONHUMAN; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION; SYNAPTIC TRANSMISSION;

EID: 0032811033     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09265.x     Document Type: Conference Paper

References (54)

1. 2 dopamine receptor blockade on zifl268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Mol. Brain Res. 35: 237-248.
2. 2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 22: 114-122.
3. 3. Pierce, R.C., K. Bell, P. Duffy & P.W. Kalivas. 1996. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16: 1550-1560.
4. 4. Reid, M.S. & S.P. Berger. 1996, Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. NeuroReport 7: 1325-1329.
5. 5. Reid, M.S., K. Hsu Jr. & S.P. Berger. 1997. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse 27: 95-105.
6. 6. Smith, J.A., Q. Mo, H. Guo, P.M. Kunko & S.E. Robinson. 1995. Cocaine increases extraneuronal levels of aspartate and glutamate in the nucleus accumbens. Brain Res. 683: 264-269.
7. 7. Dalia, A., N.J. Uretsky & L.J. Wallace. 1998. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity. Brain Res. 788: 111-117.
8. 8. Gray, A.M., S.M. Rawls, T.S. Shippenberg & J.F. McGinty. The kappa opioid agonist, U-69593, decreases amphetamine-evoked behavior and dialysate levels of dopamine and glutamate in the nucleus acumbens of awake rats. J. Neurochem. In press.
9. 9. Guix, T., Y.L. Hurd & U. Ungerstedt. 1992. Amphetamine enhances extracellular concentrations of dopamine and acetylcholine in dorsolateral striatum and nucleus accumbens of freely moving rats. Neurosci. Lett. 138: 137-140.
10. 10. Meshul, C.K. & J.F. McGinty. Kappa opioid receptor immunoreactivity in nucleus accumbens shell and caudate-putamen is primarily associated with synaplic vesicles in axons. Neuroscience. In press.
11. 11. Di Chiara, G. & A. Imperato. 1988. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244: 1067-1080.
12. 12. Spanagel, R., A. Herz & T.S. Shippenberg. 1992. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA 89: 2046-2050.
13. 13. Maisonneuve, I.M., S. Archer & S.D. Glick. 1994. U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci. Lett. 181: 57-60.
14. 14. Rawls, S.M. & J.F. McGinty. 1997. L-Trans-pyrrolidine-2,4-dicarboxylic acid-evoked striatal glutamate levels are attenuated by calcium reduction, tetrodotoxin, and glutamate receptor blockade. J.Neurochem. 68: 1553-1563.
15. 15. Rawls, S.M. & J.F. McGinty. 1998. κ Receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum. J. Neurochem. 70: 626-634.
16. 16. Rawls, S.M. & J.F. McGinty. Delta opioid receptors regulate amphetamine-evoked dialysate glutamate and dopamine levels in the rat striatum. Brain Res. In press.
17. 17. Dragunow, M., B. Logan & R. Laverty. 1991. 3,4-Methyldioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801. Eur. J. Pharmacol. 206: 255-258.
18. 18. Snyder-Keller, A.M. 1991. Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Exp. Neurol. 113: 155-165.
19. 19. Torres, G. & C. Rivier. 1993. Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists. Brain Res. Bull. 30: 173-176.
20. 20. Ohno, M., H. Yoshida & S. Watanabe. 1994. NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioral sensitization. Brain Res. 665: 135-140.
21. 21. Keefe, K.A. & C.R. Gerfen. 1996. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J. Comp. Neurol. 367: 165-176.
22. 22. Berretta, S., H.A. Robertson & A.M. Graybiel. 1993. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neuroscience 13: 423-433.
23. 23. Page, K.J. & B.J. Everitt. 1993. Transsynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neurons following AMPA-induced activation of the dorsal and ventral striatum. Exp. Brain Res. 93: 399-411.
24. 24. Vaccarino, F.M., M.D. Hayward, E.J. Nestler, R.S. Duman & J.F. Tallman. 1992. Differential induction of immediate early genes by excitatory amino acid receptor types in primary cultures of cortical and striatal neurons. Mol. Brain Res. 12: 233-241.
25. 25. Wang, J.Q., J.B. Daunais & J.F. McGinty. 1994. Role of kainate/AMPA receptors in induction of striatal zif/268 and preprodynorphin mRNA by a single injection of amphetamine. Mol. Brain Res. 27: 118-126.
26. 26. Wang, J.Q., J.B. Daunais & J.F. McGinty. 1994. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18: 343-353.
27. 27. Wang, J.Q. & J.F. McGinty. 1998. Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum. Mol. Brain Res. 54: 262-269.
28. 28. Wang, J.Q. 1998. Regulation of immediate early gene c-fos and zif/268 mRNA expression in rat striatum by metabotropic glutamate receptor. Mol. Brain Res. 57: 46-53.
29. 29. Verma, A. & B. Moghaddam. 1998. Regulation of striatal dopamine release by metabotropic glutamate receptors. Synapse (NY) 28: 220-226.
30. 30. Wang, J.Q. & J.F. McGinty. 1996. Intrastriatal injection of the metabotropic glutamate receptor antagonist MCPG attenuates acute amphetamine-stimulated neuropeptide mRNA expression in rat striatum. Neurosci. Lett. 218: 13-16.
31. 31. Wang, J.Q. & J.F. McGinty. 1996. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Neuroscience 75: 43-56.
32. 1 dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience 72: 601-616.
33. 33. Di Chiara, G., M. Morelli & S. Consolo. 1994. Modulatory functions of neurotransmitters in the striatum: Ach/dopamine/NMDA interactions. Trends Neurosci. 17: 228-233.
34. 34. Wang, J.Q. & J.F. McGinty. 1996. Glutamatergic and cholinergic regulation of immediate early gene and neuropeptide gene expression in the striatum. In Pharmacological Regulation of Gene Expression in the CNS. K. Merchant, Ed.: 81-113. CRC Press, Inc. Boca Raton.
35. 1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. J.Neurosci. 17: 8498-8505.
36. 36. Curran, E.J. & S.J. Jr. Watson. 1995. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. Comp. Neurol. 361: 57-76.
37. 2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience 82: 767-780.
38. 2 interactions by muscarinic receptors. J. Pharmacol. Exp. Ther. 281: 972-982.
39. 39. Konradi, C. & S. Heckers. 1995. Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein. Neuroscience 65: 1051-1061.
40. 40. Cole, R.L., C. Konradi, J. Douglass & S.E. Hyman. 1995. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14: 813-823.
41. 41. McCaffrey, P. & U.C. Drager. 1994. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc. Natl. Acad. Sci. USA 91: 7772-7776.
42. 42. Samad, T.A., W. Krezel, P. Chambon & E. Borelli. 1997. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc. Natl. Acad. Sci. USA 94: 14349-14354.
43. 43. Krezel, W., N. Ghyselinck, T.A. Samad, V. Dupé, P. Kastner, E. Borrelli & P. Chambon. 1998. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 279: 863-867.
44. 44. Konradi, C., J.C. Leveque & S.E. Hyman. 1996. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci. 16; 4231-4239.
45. 2+- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87: 1203-1214.
46. 46. Sgambato, V., P. Vanhoutte, C. Pagès, M. Rogard, R. Hipskind, M.-J. Besson & J. Caboche. 1998. In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J. Neuroscience 18: 214-216.
47. 47. Vanhoutte, P., J.V. Barnier, C. Pagès, M.-J. Besson, R. A. Hipskind & J. Carboche. 1999. Glutamate induces phosphorylation of ELK-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol. Cell. Biol. 19: 136-146.
48. 48. Ginty, D.D. 1997. Calcium regulation of gene expression: Isn't that spatial? Neuron 18: 183-186.
49. 1 dopamine receptors through a cAMP/protein kinase A-dependent mechanism. Nature 348: 239-242.
50. 2+ channels due to phosphorylation by cAMP-dependent mechanism. Nature 348: 239-242.
51. 51. Chetkovich, D.M. & J.D. Sweatt. 1993. NMDA receptor activation increases cyclic AMP in area CAI of the hippocampus via calcium/calmodulin stimulation of adenylyl cyclase. J. Neurochem 61: 1933-1942.
52. 2+ influx requires cAMP-dependent protein kinase in PC12 cells. J. Biol. Chem. 266: 17454-17458.
53. 53. Yakel, J.L. 1997. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol. Sci. 18: 124-134.
54. 54. Simpson, J.N., J.Q. Wang & J.F. McGinty. 1995. Repeated amphetamine administration induces a prolonged augmentation of phosphorylated cyclase response element-binding protein and Fos-related antigen immunoreactivity in rat striatum. Neuroscience 69: 441-457.